{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04823",
    "Peptide Name": "QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich,  XXA, UCLL1c)",
    "Source": "amino acid substitution, local sequence shuffling, amphibians, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLPKLLSALAKIL",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA",
      "Hemolytic",
      "Antibiofilm"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": -1.66,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "69%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (71.43%) toTemporin-WY2Leu: 38%; K=A: 15%.Chemical modification:  C-terminal amidatedActivity: active against Gram+ bacteria S. aureus ATCC CRM 6538 or MRSA BAA 1707 or clinical MRSA B038 V1S1 A (MIC 2 uM), E. faecalis NCTC 12697 (MIC 4 uM), Gram- E. coli NCTC 8739 or clinical BAA 2340 (MIC 4 uM), P. aeruginosa ATCC 9027 or PAO1 (MIC 16-64 uM), P.aeruginosa PA14 (MIC >128 uM) , K. pneumoniae ATCC 43816 (MIC 8 uM). NaCl-insensitive:E. coli (150 mM), KCl-insensitive:E. coli (4. 5 mM), NH4Cl-insensitive:E. coli (6 uM), CaCl2-sensitive:E. coli (2.5 mM), MgCl2-insensitive:E. coli (1 mM),  ZnCl2-insensitive:E. coli (8 mM), FeCl3-insensitive:E. coli (4 uM). Salt-insensitive:MRSA; Salt-insensitive:E. coli.Antimicrobial robustness: NaCl-insensitive:S. aureus (150 mM), KCl-insensitive:S. aureus (4. 5 mM), NH4Cl-insensitive:S. aureus (6 uM), CaCl2-insensitive:S. aureus (2.5 mM), MgCl2-insensitive:S. aureus (1 mM),  ZnCl2-insensitive:S. aureus (8 mM), FeCl3-insensitive:S. aureus (4 uM).   Human serum-insensitive:MRSA (%?).Biofilms: S. aureus: Inhibited formation (MBIC 4 uM) but disruption strain-dependent (MBEC 32 to >128 uM). disrupted biofilms: E. faecalis (MBEC 32 uM).Structure:  random coils in NH4AC buffer and helical in 50% TFE.In vitro toxicity: horse RBC: HC50=16-32 uM.",
    "Author": "Liao F, Ye Z, Cheng J, Zhu J, Chen X, Zhou X, Wang T, Jiang Y, Ma C, Zhou M, Chen T, Shaw C, Wang L. 2024",
    "Reference": "Sci Rep. 2024 Aug 13;14(1):18769. doi: 10.1038/s41598-024-67777-1.PubMed",
    "Title": "Discovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria"
  },
  "3D Structure": []
}